/smstreet/media/media_files/2026/01/12/sereko-2026-01-12-14-32-07.png)
SEREKO, India’s first psychodermatology-led skincare brand, has been granted a patent for its proprietary stress recovery complex NeuroCalm®, marking a milestone in the evolution of science-backed skincare in India.
Developed after two years of research and development, NeuroCalm® is a patented psychodermatology complex designed to address stress responses in the skin. The patent grant establishes SEREKO as the first Indian skincare brand to secure intellectual property in the psychodermatology space, a field that sits at the intersection of dermatology, psychiatry, and neuroscience.
The innovation was conceptualised and led by Malvika Jain, Founder & CEO of SEREKO, in collaboration with Dr. Kriti Soni, a leading cosmetic scientist. Unlike traditional formulations that focus solely on surface-level symptoms, NeuroCalm® works by supporting the skin’s response to stress, helping reduce visible stress markers while improving overall skin health and balance.
“With NeuroCalm®, we wanted to challenge the idea that skincare is only about ingredients and routines,” said Malvika Jain, Founder of SEREKO. “This patent is not just a win for us as a brand — it’s a win for Indian skincare innovation and for consumers who are looking for solutions that understand the deeper causes behind skin concerns.”
/smstreet/media/agency_attachments/3LWGA69AjH55EG7xRGSA.png)
Follow Us